Proteomic technologies for the identification of disease biomarkers in serum: advances and challenges ahead. - Wikidata - awgldk - TriplyDB

Proteomic technologies for the identification of disease biomarkers in serum: advances and challenges ahead.

Proteomic technologies for the identification of disease biomarkers in serum: advances and challenges ahead.

http://www.wikidata.org/entity/Q33891197

about

Cerebrospinal fluid biomarkers of Alzheimer’s disease The Role of Proteomics in Biomarker Development for Improved Patient Diagnosis and Clinical Decision Making in Prostate Cancer Differential denaturation of serum proteome reveals a significant amount of hidden information in complex mixtures of proteins Smart surface for elution of protein-protein bound particles: nanonewton dielectrophoretic forces using atomic layer deposited oxides What was old is new again: using the host response to diagnose infectious disease.Application of machine learning to proteomics data: classification and biomarker identification in postgenomics biology.Investigation of serum proteome alterations in human glioblastoma multiforme.Quantitative Proteomics Analysis of Plasmodium vivax Induced Alterations in Human Serum during the Acute and Convalescent Phases of Infection.Identification of urine biomarkers associated with lung adenocarcinoma.Facile synthesis of magnetic mesoporous hollow carbon microspheres for rapid capture of low-concentration peptides.Lanthanum silicate coated magnetic microspheres as a promising affinity material for phosphopeptide enrichment and identification.Proteomic investigation of falciparum and vivax malaria for identification of surrogate protein markers.Simultaneous extraction and rapid visualization of peptidomic and lipidomic body fluids fingerprints using mesoporous aluminosilicate and MALDI-TOF MS.Construction of a high-performance magnetic enzyme nanosystem for rapid tryptic digestion Identification of Enolase 1 and Thrombospondin-1 as serum biomarkers in HBV hepatic fibrosis by proteomics REPO4 (RE = La, Nd, Eu) affinity nanorods modified on a MALDI plate for rapid capture of target peptides from complex biosamples.The discovery and identification of a candidate proteomic biomarker of active tuberculosis Combined docking, molecular dynamics simulations and spectroscopic studies for the rational design of a dipeptide ligand for affinity chromatography separation of human serum albumin.Quantitative proteomic analysis of meningiomas for the identification of surrogate protein markers.Forward Look: Tenth Anniversary of the Human Genome Sequence and 21 Century Postgenomics Global Health - A Close Up on Africa and Women's Health.Biomarker discovery by novel sensors based on nanoproteomics approaches.Absolute quantification of DcR3 and GDF15 from human serum by LC-ESI MS.Influence of storage conditions on MALDI-TOF MS profiling of gingival crevicular fluid: Implications on the role of S100A8 and S100A9 for clinical and proteomic based diagnostic investigations.Proteomic technologies for the study of osteosarcoma Recent Advances on Luminescent Enhancement-Based Porous Silicon Biosensors.Weak cation exchange magnetic beads coupled with matrix-assisted laser desorption ionization-time of flight-mass spectrometry in screening serum protein markers in osteopenia.Serum proteome changes in dengue virus-infected patients from a dengue-endemic area of India: towards new molecular targets?Advances in the proteomic investigation of the cell secretome.The proteomics big challenge for biomarkers and new drug-targets discovery.Digital transplantation pathology: combining whole slide imaging, multiplex staining and automated image analysis.The clinical impact of recent advances in LC-MS for cancer biomarker discovery and verification.Contributions of immunoaffinity chromatography to deep proteome profiling of human biofluids Sources of technical variability in quantitative LC-MS proteomics: human brain tissue sample analysis Proteomic analysis of bronchoalveolar lavage fluid (BALF) from lung cancer patients using label-free mass spectrometry.Current advantages in the application of proteomics in inflammatory bowel disease.Interferometric silicon biochips for label and label-free DNA and protein microarrays.Update on the proteomics of major arthropod vectors of human and animal pathogens.Differential expression of serum/plasma proteins in various infectious diseases: specific or nonspecific signatures.The role of proteomics in understanding biological mechanisms of sepsis.Proteomic analysis of cerebrospinal fluid in California sea lions (Zalophus californianus) with domoic acid toxicosis identifies proteins associated with neurodegeneration.

P2860

Q22252572-E2864D0F-4D33-4149-9FE6-6B5B7E79FEAF Q26738703-88F7C5BB-D067-41FA-81D9-D330DD3E84CE Q28488743-21E91760-1AF9-469B-883B-D38A5E33AE7E Q28830310-834FE8F9-40E1-4F09-84C3-213F9F2CE201 Q30376327-B727015D-6A12-43F3-925E-2887A63BF004 Q30676067-25395FA5-E190-4ECD-A285-6CFB3454D4D9 Q31063977-1ECFDE1A-D398-4503-ADE8-6ED30C16D17F Q33860793-5E963382-7859-4C1E-93C9-34540295C53C Q33888856-6626FB61-5F96-4530-A4AB-C85AF8D68798 Q34050535-CD84B7F9-3A97-4FB6-AEA5-695E015CFB4C Q34313411-50A1B165-1894-463F-82B6-84687FB25555 Q34388636-A6509941-50F0-47F7-97D8-53B176ADD48F Q34418701-A42E279A-BE4A-43C4-A321-7C28CCF5A433 Q34460560-C9C88606-6E8F-4066-B41B-ED954DF91E46 Q34812703-60CDA76F-9F12-44AB-9B20-E7518C8B8C3E Q34930216-6B547007-13D6-4BD4-BB83-A13EFBBF428A Q35028192-2EBF8D91-B49F-43FA-924E-4FF119EAA436 Q35252046-25F5BE67-179D-4CF8-B66D-15EA4B178B2C Q35440783-DF1081C3-4943-44DB-A25E-269851B647E9 Q35690458-344B9BB9-C75D-4E5C-AE18-A5EC05A24FE1 Q35831485-233F9649-619F-4110-A7E1-22EF70033368 Q35879535-4CF55A06-9B3D-456B-BFA4-CCC36D6A399F Q35880037-82DA8BB8-96AF-4F65-9AC6-4133216B5B24 Q35897776-769D0D78-E4CE-4507-9B86-46810551D1F4 Q35936196-4056BD1D-C89C-4E91-833C-447FC2043384 Q36062140-33A2D6CF-6D53-4BEA-A4AA-6AA1F28BD66A Q36283254-34001CEC-2CBC-4DFA-BC26-AB3081052A2C Q36406560-8ABF9F28-2D69-4E63-9CBB-A1DEEC5871BD Q36432402-387C92F2-A8D7-4475-AC7B-3B3D33E8BB64 Q36769130-3D9127D6-E20C-45D1-AB11-DBB4F87E41B4 Q36771005-C2DD536B-B451-49CB-A96B-41FC6E38AC1C Q36889137-4C33FB59-9856-48F7-99C4-B84476400437 Q36963132-DA7236F0-C553-4027-8FD8-03E2F34CFBAD Q37710444-4BF8AF93-32A7-4AD8-AB23-6222483CCE23 Q38022190-E4CB7D3C-120D-44B9-90AE-9C4963ED8E81 Q38038828-8D513335-1AE4-4B32-BC38-537741699951 Q38053132-7CF10C3F-DA41-43A6-9CDA-A3E2F67C9BDA Q38167708-2A006A9C-4D4F-42C2-A75D-50BB4086306F Q38171431-CD6BCBA7-009D-4831-A3DC-AE7664F7CCF1 Q38403840-C92E1E77-2EBF-43F5-AD41-0CE60BC8B332

P2860

Proteomic technologies for the identification of disease biomarkers in serum: advances and challenges ahead.

http://www.wikidata.org/entity/Q33891197

description

2011 nî lūn-bûn

@nan

2011 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Proteomic technologies for the ...... advances and challenges ahead.

@ast

Proteomic technologies for the ...... advances and challenges ahead.

@en

type

label

Proteomic technologies for the ...... advances and challenges ahead.

@ast

Proteomic technologies for the ...... advances and challenges ahead.

@en

prefLabel

Proteomic technologies for the ...... advances and challenges ahead.

@ast

Proteomic technologies for the ...... advances and challenges ahead.

@en

P1433

Q33891197-3436891C-8D1D-4A38-B41B-BA8D6719F5B7

P1476

Q33891197-7CF1AC13-57AB-4093-B414-7429F7A97303

P2093

Q33891197-0C0C8CAA-9C36-44BB-A8E1-9D79E67356B6

Q33891197-15018CD4-14D5-46D8-9418-26CCF348CE8E

Q33891197-8FEF9EF6-00F0-48F0-9217-71EE0FC3C5CD

Q33891197-B86940CA-E747-4B17-B950-B091480505E5

Q33891197-D31BF72A-7675-4BF7-9580-1725C6FBFBF0

Q33891197-D51F185B-BE8A-417F-839F-E1056F55E34D

P2860

Q33891197-03BF1122-503B-43C6-BBDF-2801BFD059CC

Q33891197-03F8BCE0-0E5D-40F3-B3A0-65EE06EF10CF

Q33891197-0464001D-CFDF-4729-997F-5E6F8E766500

Q33891197-0802317B-D957-4EE9-A606-0C4D352846E5

Q33891197-0A3C87DF-7AE0-47FE-A255-F8E1E882D27B

Q33891197-0A460CFC-6485-434D-B25B-BA1BFFCBDA6E

Q33891197-0A734E09-47C4-423E-834C-17135600A9AF

Q33891197-0FA6C2D3-C747-4588-AF47-EA4E4CF6E115

Q33891197-0FBD5498-C4E5-470B-A92C-7144205D5FAC

Q33891197-0FCC9109-2938-4CC2-809A-7F26679C1A1F

P304

Q33891197-A27149D0-38C0-4FCB-BF1C-57FA8BB1D178

P31

Q33891197-5E89185F-ED6D-41E4-B808-1E68B72249F0

P356

Q33891197-7C0A021D-18CB-4BDC-9B6D-6742A9C7DC12

P433

Q33891197-FCF4CD54-4DB3-4F78-96DC-D7788AA0BF53

P478

Q33891197-30F02DF0-3E5A-49D3-9FD5-269A8BB12594

P577

Q33891197-B5DAFD91-A94E-4A12-B0C2-CB681653D25A

P5875

Q33891197-C365BD4D-42B3-4ADD-9627-5FB4F8239FB9

P698

Q33891197-5D13BA6F-2AF3-4BA4-AF87-D993B45E531C

P921

Q33891197-E4D73093-EE74-4C43-9178-115DFEF74C0E

P356

P1433

P1476

Proteomic technologies for the ...... advances and challenges ahead.

@en

P2093

Aliasgar Moiyadi

http://www.w3.org/2001/XMLSchema#string

Kishore Gollapalli

http://www.w3.org/2001/XMLSchema#string

Panga J Reddy

http://www.w3.org/2001/XMLSchema#string

Rekha Jain

http://www.w3.org/2001/XMLSchema#string

Sandipan Ray

http://www.w3.org/2001/XMLSchema#string

Sanjeeva Srivastava

http://www.w3.org/2001/XMLSchema#string

P2860

Current two-dimensional electrophoresis technology for proteomics

An investigation into the human serum "interactome"

8-plex quantitation of changes in cerebrospinal fluid protein expression in subjects undergoing intravenous immunoglobulin treatment for Alzheimer's disease

Quantitative analysis of complex protein mixtures using isotope-coded affinity tags

Mass spectrometry-based proteomics

Properties of 13C-substituted arginine in stable isotope labeling by amino acids in cell culture (SILAC)

Clinical proteomics: written in blood

The human plasma proteome: history, character, and diagnostic prospects

Design of recombinant antibody microarrays for complex proteome analysis: choice of sample labeling-tag and solid support

Difference gel electrophoresis: a single gel method for detecting changes in protein extracts

P304

2139-2161

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/PMIC.201000460

http://www.w3.org/2001/XMLSchema#string

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

11

http://www.w3.org/2001/XMLSchema#string

P577

2011-05-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51103562

http://www.w3.org/2001/XMLSchema#string

P698

21548090

http://www.w3.org/2001/XMLSchema#string

P921